Article info

Download PDFPDF
Extended report
Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rβ2 inhibition
  1. Correspondence to Professor Pierre Miossec, Clinical Immunology Unit, Department of Immunology and Rheumatology, Edouard Herriot Hospital, 5 Place d'Arsonval, 69437 Lyon Cedex 03, France; miossec{at}univ-lyon1.fr
View Full Text

Citation

Toh M, Kawashima M, Hot A, et al
Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rβ2 inhibition

Publication history

  • Accepted January 31, 2010
  • First published June 11, 2010.
Online issue publication 
July 21, 2010

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.